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Deletion of the innate immune adaptor myeloid differentiation
primary response gene 88 (MyD88) in the nonobese diabetic (NOD)
mouse model of type 1 diabetes (T1D) results in microbiota-depen-
dent protection from the disease: MyD88-negative mice in germ-
free (GF), but not in specific pathogen-free conditions develop the
disease. These results could be explained by expansion of particular
protective bacteria (“specific lineage hypothesis”) or by dominance
of negative (tolerizing) signaling over proinflammatory signaling
(“balanced signal hypothesis”) in mutant mice. Here we found that
colonization of GF mice with a variety of intestinal bacteria was
capable of reducing T1D in MyD88-negative (but not wild-type
NOD mice), favoring the balanced signal hypothesis. However, the
receptors and signaling pathways involved in prevention or facilita-
tion of the disease remained unknown. The protective signals trig-
gered by the microbiota were revealed by testing NOD mice lacking
MyD88 in combination with knockouts of several critical compo-
nents of innate immune sensing for development of T1D. Only
MyD88- and TIR-domain containing adapter inducing IFN β (TRIF)
double deficient NODmice developed the disease. Thus, TRIF signal-
ing (likely downstream of Toll-like receptor 4, TLR4) serves as one of
the microbiota-induced tolerizing pathways. At the same time an-
other TLR (TLR2) provided prodiabetic signaling by controlling the
microbiota, as reduction in T1D incidence caused by TLR2 deletion
was reversed in GF TLR2-negative mice. Our results support the
balanced signal hypothesis, in which microbes provide signals that
both promote and inhibit autoimmunity by signaling through dif-
ferent receptors, including receptors of the TLR family.
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It has been established that the commensal microbiota is animportant environmental factor that regulates autoimmunity.
The range of microbial influences varies with the type of auto-
immunity from protection (1, 2), to no influence (3), to stimu-
lation (4–6). Additionally, it has been demonstrated that host
genetics plays an important role in shaping the microbiota (7).
Our previous report (8) has shown that type 1 diabetes (T1D)-
prone nonobese diabetic (NOD) mice that have lost signaling by
the majority of Toll-like receptors (TLRs), due to genetic abla-
tion of the myeloid differentiation primary response gene 88
(MyD88) adaptor protein, were protected from the disease. The
protection required microbes, because germ-free (GF) MyD88-
negative mice did develop T1D. The original explanation for these
observations was that in the absence of MyD88 some particular
microbial lineages were amplified and induced tolerogenic signal-
ing. The hypothesis was later termed the “specific lineage hypoth-
esis” (9). However, we also recognized that microbes stimulate both
the microbial control mechanisms of the host and mechanisms that
reduce the host’s control over the microbiota. It is possible that the
balance of these signals (“balanced signal hypothesis”) is important
for the initiation of autoimmunity (9). This hypothesis assumes that
the negative regulatory mechanisms that pacify the antimicrobial
responses also lead to tolerance to self-antigens. It also suggests that
given the richness of the normal microbiota, the role of specific
lineages may not be crucial in eliciting tolerizing signals. The type of
receptors and signaling pathways involved in microbiota-dependent
protection from T1D remained unknown.
Here, we sought to identify such pathway(s). We used genetic
approaches, in which we tested NOD mice deficient in different
innate signaling pathways for their ability to develop T1D as well
as when these deficiencies were combined with the lack of MyD88
signaling. The results suggest that both pro- and antiinflammatory
signaling in T1D is primarily regulated by TLRs.
Results
Distinct Bacterial Lineages Can Reduce Diabetes Incidence in Gnotobiotic
MyD88-Negative NOD Mice. The alternative to the balanced signal
hypothesis, which explains the microbiota dependence of autoim-
munity development by the competition of host-driven and mi-
crobe-driven mechanisms, and which is heavily influenced by the
genetics of the host, is the specific microbial lineage hypothesis (9).
The latter suggests that because genetic variations of the host can
affect microbial communities (7), the expanded lineages can po-
tentially affect the course of autoimmunity development. In fact,
MyD88-negative NOD mice did show statistically significant ex-
pansion of several bacterial lineages (8), including Lactobacillacae.
Because gnotobiotic NOD mice are the most useful tools for
testing a putative role of bacterial lineages in T1D development,
we colonized GF NOD and GF NOD MyD88-deficient mice with
a probiotic mix, VSL3, containing several strains of Lactobacillacae.
Histopathology of the islets was assessed at the age of 13 wk
(Fig. 1). We have previously established (10) that percentage of
islets with bona fide insulitis at this age quite accurately predicts
overt diabetes development in the respective animal cohort. Col-
onization with VSL3 did not affect insulitis in the wild-type NOD
mice, but suppressed it in MyD88-negative gnotobiotic NOD
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mice. Moreover, we have previously found (8) that a bacterial
community termed “altered Schaedler’s flora” (ASF) has reduced
T1D incidence and histopathology (Fig. 1) in colonized NOD
MyD88-deficient mice, suggesting that various bacterial lineages can
reduce T1D in MyD88-negative mice. Whereas VSL3 is a probiotic
based on human isolates, ASF is a community of microbes normally
present in the mouse gut. In addition to these bacterial communi-
ties, we introduced a single microbe, segmented filamentous bac-
teria (SFB) into GF NOD mice. SFB also reduced T1D incidence
(7) and histopathology at 13 wk (Fig. 1) in MyD88-negative mice.
Thus, multiple and very different bacterial lineages can contribute
to protection of MyD88-negative, but not wild-type NOD mice.
None of these lineages offered a complete protection compared
with specific pathogen-free (SPF) MyD88-negative animals, in-
dicating that more than one pathway, likely triggered by different
microbial agonists, could contribute to protection when the adaptor
MyD88 is disabled. These results argued in favor of the balanced
signal hypothesis.
Testing the Balanced Signal Hypothesis: Several Non-TLR Bacteria-
Sensing Mechanisms Do Not Protect from Diabetes. To test the
balanced signal hypothesis, it was important to uncover MyD88-
independent bacteria-sensing mechanisms that may contribute to
protection from T1D. We used a genetic approach in which we
first tested a specific pathway for its requirement for T1D devel-
opment per se, and then determined whether its inactivation
rescues T1D development in MyD88-deficient NOD mice.
Signaling through a complex of signaling molecules termed
“the inflammasome” is required to produce effector cytokines.
IL1/IL18-induced signaling had previously been shown to be dis-
pensable for T1D development (11) in caspase 1-negative NODs.
Because receptors for IL1 and IL18 also signal through MyD88,
the classical processing of these cytokines by inflammasome-acti-
vated caspase 1 cannot lead to protection from T1D in MyD88-
negative NOD mice. However, the caspase 1 knockout has been
shown to be a double knockout: the caspase 11 gene has also been
inactivated (12). Caspase 4/11 oligomers can bind LPS and acti-
vate yet another MyD88-independent signaling cascade (13). Thus,
we have crossed Casp1/11−/− mice to MyD88−/− NOD mice to
produce double knockout animals (Fig. 2A). The deletion of cas-
pase 11 did not change the outcome of disease development:
double knockout mice were still protected from T1D, indicating
that the LPS–caspase 11 pathway is not involved in the microbiota-
induced protection.
The NOD-like receptor (NLR) family is another group of
intracellular receptors that represent a key component of the
innate immune system. NOD1 and NOD2 recognize the bacterial
cell wall component peptidoglycan. Ligand-bound NOD1 and
NOD2 oligomerize and signal through the serine-threonine RIP2
kinase via CARD–CARD homophilic interactions (14). Upon
activation, RIP2 mediates ubiquitination of NEMO/IKKγ, which
results in the activation of NF-κB and the production of in-
flammatory cytokines. To test the role of NLRs in generating the
protective signal from the microbiota, we have backcrossed Ripk2-
negative C57BL/6 mice (14) to NOD mice for 10 generations.
Importantly, NOD Ripk2-negative mice were sensitive to T1D
(Fig. 2B) similarly to wild-type NODs or heterozygous controls.
We then bred Ripk2-negative mice to MyD88-deficient NOD
mice. The double knockout of Ripk2 and MyD88 was in-
distinguishable from the single MyD88 knockout. Thus, we con-
cluded that the protective signal in the absence of MyD88 was not
a result of signaling through the RIP2-dependent NLR family of
innate immune receptors.
Testing the Balanced Signal Hypothesis: The Signaling Adaptor TRIF
Participates in Microbiota-Dependent Protection from T1D. TLRs
signal through two alternatively used adaptors, MyD88 and TRIF
(encoded by the Ticam1 gene). Some reports have suggested that
TRIF signaling could be a negative regulator of immunity (15–17).
Thus, we have crossed TRIF-negative mice to the NOD strain for
10 generations and then to MyD88-negative NOD mice. TRIF
deficiency did not affect T1D in MyD88-sufficient NOD mice, but
reversed the protection significantly (although partially) in double-
negative mice (Fig. 3A). Given the level of protection offered by
MyD88 deficiency in SPF mice (100% at the University of Chicago
Fig. 1. Distinct bacterial lineages reduce diabetes incidence in gnotobiotic
MyD88-negative NOD mice. Bona fide insulitis (percentage of total islets) in
13-wk-old female MyD88+/+ or MyD88−/− mice in SPF and GF conditions and
colonized with ASF, VSL3, or SFB. n = number of mice per group. P values for
histopathology were determined by Student’s t test. *P < 0.05, **P < 0.01,
***P < 0.001.
Fig. 2. Non-TLR bacteria-sensing mechanisms do not protect from diabetes.
(A) Diabetes incidence in NOD female caspase 1/11+/−, caspase 1/11−/− lit-
termates, and MyD88−/− caspase 1/11+/−, MyD88−/− caspase 1/11−/− litter-
mates. (B) Diabetes incidence in NOD female Ripk2+/−, Ripk2−/− littermates
and MyD88−/− Ripk2+/−, MyD88−/− Ripk2−/− littermates. n = number of mice
per group. P values for incidence were determined using Kaplan–Meier
statistics. *P < 0.05, **P < 0.01, ***P < 0.001. ns, nonsignificant, P > 0.05.
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facility), even 25% reversal (at 30 wk of age) was significant and
important. This conclusion was strengthened by examination of
islet histopathology at 30 wk of age (Fig. 3 B–D). A significantly
higher number of islets with insulitis were observed in double
knockout mice compared with MyD88 single knockout animals
(Fig. 3B). TRIF+/− littermates of double-negative mice were
treated as a separate group to ensure that the same input micro-
biota was acquired by experimental and control animals. Addi-
tionally, histological examination was scored to include the
numbers of intact islets and islets with periinsulitis (Fig. 3C and
Fig. S1). Fig. 3D shows examples of islet pathology in four groups
of mice (NOD, NOD.MyD88−/−, NOD.TRIF−/−, and NOD.
MyD88−/−TRIF−/−. Thus, signaling through TRIF, which is linked
to TLR4 and TLR3 upstream receptors, contributes to protection
from T1D in MyD88-deficient mice.
Testing the Balanced Signal Hypothesis: Antimicrobial TLR-Dependent
Mechanisms Favoring T1D Development in NOD Mice. To explain the
protective role of the loss of MyD88 in SPF mice, we suggest that
MyD88-dependent antimicrobial mechanisms are normally bal-
ancing out the pacifying signals from the commensal microbiota.
Efficient T1D development in caspase 1-negative NOD mice
(11) has indicated that the MyD88-dependent antimicrobial
pathways in NOD mice were not based on signaling through IL1
or IL18 receptors, which involve MyD88, but rather on TLRs.
Moreover, previous studies (8, 18) found that genetic ablation of
different TLRs had different effects on T1D development in SPF
mice. In particular, genetic ablation of TLR9 (18) and TLR2
(19) partially reduced T1D incidence. The loss of T1D in TLR2-
and TLR9-deficient mice could be explained by either their di-
rect contribution to T1D development or by their input in the
overall control over microbes that reduce the microbial negative
regulation of T1D. To discriminate between these possibilities,
we have rederived TLR2-negative NOD mice into GF conditions
and followed T1D development in these mice. TLR2-negative
SPF mice had lost about one-half of their capacity to cause T1D
in SPF mice as expected. However, GF TLR2-negative mice
developed T1D with high incidence (Fig. 4A) and had increased
histopathology (Fig. 4 B and C) compared with SPF TLR2-
negative NOD. Thus, the prodiabetic effect of TLR2 was indirect
and its knockout allowed microbes to reduce T1D incidence.
Interestingly, previous reports found that ablation of TLR3
had no effect on T1D (18), whereas the knockout of TLR4
shifted T1D development curves toward earlier time points (20,
21) promoting the disease. These results suggested that TLR4
was activating a MyD88-independent (MyD88 knockout had the
opposite result) signaling pathway that favored tolerance in-
duction rather than disease promotion. To test whether TLR4
promoted tolerogenic signaling in a microbiota-dependent manner,
we rederived NOD TLR4-negative mice into GF conditions and
followed T1D incidence comparing it to the incidence in SPF con-
ditions (Fig. 4D). As expected, TLR4-negative SPF mice demon-
strated some acceleration of T1D, but in GF conditions they did not
differ from TLR4-sufficient mice. These results indicate that TLR4
signaling actually represents a protective signal from the microbiota
to reduce T1D development. On the other hand, TLR2 (and pos-
sibly TLR9, which has not been tested in GF conditions) contributes
to antimicrobial control and thus indirectly to T1D development.
Discussion
Microbial regulation of autoimmunity may be explained by sev-
eral potential mechanisms. These include molecular mimicry,
which is based on cross-reactivity of effector lymphocytes to
microbial and host peptides or proteins (in the case of anti-
bodies); bystander activation of “adaptive” autoimmunity by antigen-
presenting cells (APCs) activated by microbial stimuli and expressing
self-antigens; and interference with the process of activation of in-
nate immune mechanisms (4, 22–25). The dissection of mechanisms
by which microbes can influence the development of autoimmunity
is not a simple task. There are several levels of complexity. First,
host-commensal symbiosis is generally mutualistic, but the loss of
innate control mechanisms leads to damage by symbiotic microbes
Fig. 3. Signaling adaptor TRIF participates in microbiota-dependent protection from T1D. (A) Diabetes in NOD female TRIF+/−, TRIF−/− littermates and
MyD88−/− TRIF+/−, MyD88−/− TRIF−/− littermates. (B) Bona fide insulitis (percentage of total islets) in diabetic or nondiabetic 30-wk-old female mice: NOD.
MyD88+/+ TRIF+/− and NOD.MyD88+/+ TRIF−/− littermates, NOD.MyD88−/−TRIF+/+, as well as NOD.MyD88−/− TRIF+/− and NOD.MyD88−/− TRIF−/− littermates.
(C) Full histopathology scores from mice shown in B. No insulitis (score 0), periinsulitis (score I), and insulitis (score II). (D) Representative images of islet
histology in the nondiabetic 30-wk-old mice. n = number of mice per group. P values for incidence were determined using Kaplan–Meier statistics, for
histopathology by Student’s t test. *P < 0.05, **P < 0.01, ***P < 0.001.





















(26, 27), indicating that this type of relationship is tightly controlled.
Second, microbial communities are very complex, making it difficult
to identify specific lineages that could be beneficial or detrimental.
Moreover, it could be specific fraternities of microbes and not spe-
cific individual lineages that exert regulatory functions in autoim-
munity. Finally, microbial communities are variable between
individuals, as well as between animal colonies (and over time within
the same colony), or even individual cages within the same facility.
These factors make the task of assigning an important role in au-
toimmunity to particular lineages in humans and experimental ani-
mals extremely difficult.
Because the principal goal of studies of the microbiota in
autoimmunity is the ability to influence disease development by
either manipulating the microbiota or by manipulating the sig-
naling pathways that the microbiota uses to regulate autoim-
munity, we reasoned that identification of the host pathways and
their agonists would be the most feasible approach to address the
problem. For that reason, the current study was focused on
testing the role of known innate signaling receptors in microbial-
mediated manipulation of T1D.
Our results indicate that TLRs play a critical role in the mi-
crobial contribution to T1D development. The presence of com-
mensal microbes is not required for T1D development in rodents,
as demonstrated for both mice and rats (8, 28, 29). Thus, TLRs
play regulatory rather than causative roles. As shown here, a
prodiabetic MyD88-dependent signal is provided in part through
activation of TLR2, and this prodiabetic activity is lost in GF
conditions. Previous work also identified TLR9 as sustaining dis-
ease incidence in SPF conditions. Thus, observation under GF
conditions of TLR9 and double TLR9/2 knockouts under SPF
conditions would be important to determine whether TLR2 and
TLR9 together are sufficient to promote T1D by curbing tolerizing
signals induced by the microbiota.
Importantly, here we report that TRIF signaling provides a
protective signal in T1D. This finding suggests that protective
signaling occurs by activation of either TLR3 or TLR4. The facts
that TLR4-negative SPF mice (20), but not TLR3-negative SPF
mice (18), have accelerated T1D and that GF TLR4-negative
mice have normal T1D incidence, argue in favor of TLR4/TRIF
signaling being a negative regulatory pathway and protective
against T1D. TLR4 has been shown to mediate negative regula-
tion of immunity against a retrovirus, which triggers TLR4 with
bacterial LPS acquired in the gut (30). Further validation of the
role of these receptors in a straightforward experiment (pro-
duction of double knockouts with MyD88) is complicated by low
survival rates of such double knockout mice after birth. An al-
ternative experiment with tissue-specific conditional removal of
these receptors may be more fruitful. It has to be acknowledged
that the removal of TRIF in MyD88-negative mice provides sig-
nificant restoration of insulitis and only partial restoration of overt
T1D. This could be explained by involvement of other negative
signaling pathways in addition to TRIF. A similar conclusion can
be drawn from experiments with gnotobiotic mice lacking the
MyD88 adaptor, which were protected from T1D to various de-
grees by various bacterial lineages, but never completely compared
with the SPF MyD88-negative NOD mice (Fig. 1 and refs. 8, 10).
In sum, evidence collected so far implicates TLRs in both
prodiabetic and antidiabetic regulatory mechanisms. Additional
experiments are required to determine other important regula-
tory pathways and the cell types critical for protection from T1D
by commensal microbes. These advances will bring us closer to
the potential development of novel therapeutic approaches
for autoimmunity.
Materials and Methods
Mice. NOD/ShiLtJ (The Jackson Laboratory) mice were kept under SPF and
GF conditions at the University of Chicago Animal Resource Center. TLR4-
negative C57BL/10ScN mice were originally purchased from the NIH and
backcrossed to NOD/ShiLtJ mice for more than 10 generations. TLR2 B6 mice
were a gift from S. Akira, Osaka University, Osaka, and were backcrossed to
NOD/ShiLtJ for more than 10 generations. Caspase 1/11-negative NOD mice
were purchased from The Jackson Laboratory. C57BL/6J-Ticam1Lps2/J mice
purchased from The Jackson Laboratory and B6.129S1-Ripk2tm1Flv were
backcrossed to NOD/ShiLtJ for over 10 generations and intercrossed to
Fig. 4. Antimicrobial TLR-dependent mechanisms favor T1D development in NOD mice. (A) Diabetes incidence in NOD SPF and GF female TLR2 +/− and TLR2−/−
littermates. (B) Bona fide insulitis in diabetic or 30-wk-old nondiabetic female mice housed in SPF or GF conditions. NOD.TLR2+/− and NOD.TLR2−/− littermates were
used in these experiments. (C) Full histopathology scores in mice shown in B. (D) Diabetes incidence in female NOD SPF and GF TLR4+/− and TLR4−/− littermates. The
difference between SPF TLR4+/− (n = 21) and SPF TLR4−/− (n = 17) was significant (P = 0.04). The difference between GF TLR4+/− (n = 11) and GF TLR4−/− (n = 10) was
not significant (P = 0.84). n = number of mice per group. P values for incidence were determined using Kaplan–Meier statistics, for histopathology by Student’s t
test. *P < 0.05, **P < 0.01, ***P < 0.001.
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produce knockout and heterozygous animals for observation of diabetes
incidence and histologic examination of islet infiltration.
The chromosomal locations of the targeted genes were as follows:MyD88,
Chr9(119335934–119341411); TRIF(Ticam1), Chr17 (56269319–56276786);
Casp1, Chr9 (5298517–5307265); Tlr2, Chr3 (83836272–83841767); Tlr4,
Chr4 (66827584–66930284); and Ripk2, Chr4 (16122733–16163647) according to
the Mouse Genome Informatics database (www.informatics.jax.org/genes.shtml).
GF animals were rederived from NOD/ShiLtJ females impregnated by
TLR2−/− and TLR4−/− NOD males and kept GF at the University of Chicago.
GF status of mice was monitored by bacterial culture, aerobic and anaerobic
fecal cultures. Additionally, PCR amplification of bacterial 16S rRNA genes
from fecal DNA was performed as previously described (30). VSL3 was in-
troduced to GF NOD mice by gavaging GF NOD mice with VSL3 probiotic mix
in 1× PBS.
SPF mice were fed 7913 NIH-31 modified open formula mouse autoclav-
able diet (Harlan Laboratories). GF mice received autoclaved LabDiet 5K67.
All experiments were performed in accordance with both The University of
Chicago Animal Care and Use Committee and national guidelines.
Diabetes Testing. Diabetes development was monitored from 10 wk of age by
weekly testing of urine glucose with Diastix strips (Bayer). Mice were con-
sidered diabetic following two consecutive tests with urinary glucose con-
centrations over 500 mg/dL.
Histopathology of Diabetes. Pancreas tissue was removed from mice, and
hematoxylin and eosin–stained sections were made for histological analysis.
The severity of islet inflammation was determined by scoring the degree of
the inflammatory cellular infiltration. Briefly, at least 100 islets per group of
animals were scored with pancreatic sections cut at 40-μm intervals and
graded as follows: 0, no visible infiltration; I, periinsulitis; and II, bona fide
insulitis. At 13 wk of age, only the percentage of islets with bona fide
insulitis was found to predict overt diabetes (10).
Statistical Analysis. Statistical analysis of diabetes incidence was performed by
Kaplan–Meier with Prism 5 (GraphPad). Statistical analysis of histology
scoring was performed with Prism 5. Results are expressed as means ± SEM.
The statistical difference between two groups was determined by Student’s t
test. For multiple groups, the statistical difference was determined with one-
way ANOVA. A P value of <0.05 was considered statistically significant.
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